Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Net Equity Issued and Repurchased (2010 - 2026)

Palatin Technologies' (PTN) quarterly Net Equity Issued and Repurchased came in at -$562.0 in Q1 2026, down 100.21% YoY from $271037.0 in Q1 2025, and down 100.02% on a QoQ basis from $3.5 million in Q2 2025.

Palatin Technologies (PTN) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 15 years of Net Equity Issued and Repurchased data on file, last reported at -$562.0 in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 100.21% year-over-year to -$562.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 1451.06% YoY) and the FY2025 annual result came in at $8.0 million, down 45.72% from the prior year.
  • Net Equity Issued and Repurchased eased to -$562.0 in Q1 2026, from $3.5 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $10.0 million in Q4 2022 to a low of -$27737.0 in Q2 2024.
  • A 5-year average of $3.3 million and a median of $1.0 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased slumped 102.68% — and 2025, when it soared 12730.22%.
  • Tracing PTN's Net Equity Issued and Repurchased over 5 years: stood at $10.0 million in 2022, then plunged by 49.81% to $5.0 million in 2023, then slumped by 100.55% to -$27737.0 in 2024, then soared by 12730.22% to $3.5 million in 2025, then tumbled by 100.02% to -$562.0 in 2026.
  • The last three Net Equity Issued and Repurchased figures came in at -$562.0 (Q1 2026), $3.5 million (Q2 2025), and $271037.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Palatin Technologies 40.37 Mn 40.37 Mn - -562.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -562.00
Mar 31, 2026 -562.00
Jun 30, 2025 3.50 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 271,037.00
Mar 31, 2025 271,037.00
Jun 30, 2024 -27,737.00
Jun 30, 2024 -27,737.00
Mar 31, 2024 9.16 Mn
Mar 31, 2024 9.16 Mn
Dec 31, 2023 5.00 Mn
Dec 31, 2023 5.00 Mn
Sep 30, 2023 531,369.00
Sep 30, 2023 531,369.00
Jun 30, 2023 1.03 Mn
Jun 30, 2023 1.03 Mn
Dec 31, 2022 9.96 Mn
Dec 31, 2022 9.96 Mn
Jun 30, 2020 6,000.00
Jun 30, 2020 6,000.00